Average Insider

Where insiders trade, we follow

$TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Healthcare
Sector
Medical - Devices
Industry
Waleed H. Hassanein
CEO
728
Employees
$92.00
Current Price
$4.90B
Market Cap
52W Low$60.10
Current$92.0033.3% above low, 66.7% below high
52W High$156.00

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00--All Sells
Sells12$385,463.644,059
1 monthBuys00--All Sells
Sells12$385,463.644,059
2 monthsBuys00--All Sells
Sells12$385,463.644,059
3 monthsBuys11$109,057.681,3361:3.53
Sells12$385,463.644,059
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Nov 9, 2026
TOBIN JAMES R
Director
Sale4,000$94.98$379,920.00View Details
Nov 9, 2026
TOBIN JAMES R
Director
Sale59$93.96$5,543.64View Details
Sep 11, 2026
Weill David
Director
Purchase1,336$81.63$109,057.68View Details
12 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Nov 5, 2026
EPS
Estimated$0.30
ActualN/A
Revenue
Estimated$178.06M
ActualN/A
Nov 4, 2026
EPS
Estimated$0.30
ActualN/A
Revenue
Estimated$178.05M
ActualN/A
2 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.10.12